Specialized Medical Company (TADAWUL:4019)
Saudi Arabia · Delayed Price · Currency is SAR 16.59
-0.21 (-1.25%)
Jun 11, 2026, 3:19 PM AST
TADAWUL:4019 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, TADAWUL:4019 stock has a consensus rating of "Buy" and an average price target of SAR 28.05. The average 1-year stock price forecast is 69.08% higher than the current stock price, while the lowest is SAR 22.60 (+36.23%) and the highest is SAR 33.50 (+101.93%).
Price Target: SAR 28.05 (+69.08%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TADAWUL:4019 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Nov '25 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 |
Financial Forecast
Revenue This Year
1.60B
from 1.54B
Increased by 4.26%
Revenue Next Year
1.81B
from 1.60B
Increased by 12.91%
EPS This Year
0.90
EPS Next Year
1.10
from 0.90
Increased by 22.22%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6B | ||
| Avg | 1.6B | ||
| Low | 1.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.3% | ||
| Avg | 4.3% | ||
| Low | 4.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.90 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | 22.2% | |
| Low | - |